AKKA TECHNOLOGIES AKA
Last Post: 10/05/2012 9:32:09 AM
Board Marks: 0
Posts Today: 0
Board Views Today: 2
Recent Articles
- Ten Years of the Sunhak Peace Prize Celebrating Global Leaders
- ImmVira Launches Innovative Exosome, Transforming Cosmetics
- Gerresheimer Experiences Revenue Growth with Bormioli Pharma
- Tallinna Sadam Reports Q1 Cargo and Passenger Volume Trends
- Vopak Secures EUR 560 Million for Strategic Growth and Sustainability
- EfTEN Real Estate Fund Achieves Key Financial Milestones
- Innovative Satellite-Enabled IoT Transactions with SEALCOIN
- AS Ekspress Grupp Reports Positive Growth in Digital Subscriptions
- Borregaard ASA Announces Ex-Dividend Trading Notification
- CARBIOS Showcases 2024 Financial Results and Future Strategy
- Mowi ASA Reports Higher Harvest Volumes and Earnings for Q1 2025
- Unleashing Adventure: Jeep Brand at the Easter Jeep Safari
- ROLLER Named Among Top Workplaces, Celebrates Culture and Growth
- Brown, Neri, Smith & Khan LLP Celebrates Recognition in 2025
- Wei Zhou at Harvard Forum: Insights on AI and Venture Capital
- ADT Inc. Schedules Q1 2025 Financial Results Conference Call
- Koil Energy Solutions Prepares for 2024 Financial Insights
- Plume to Revolutionize Gold Investment with Matrixdock's XAUm
- Cboe Global Markets Welcomes Wei Liao to Enhance APAC Division
- Significant Growth Forecast for UV-Curable Resins Market
- Key Lawsuit Update for Atkore Inc. Investors – Act Now!
- California Science Center Hosts Unique Murals for Exhibition
- MASS Coalition Urges Reform on Skin Substitute Payment Issues
- Lindian Resources Kicks Off Development at Kangankunde Project
- MSP Recovery Unveils Major Restructuring Plan for Growth
- Prospera Energy Strengthens Leadership and Operations Strategy
- Consumer Watchdog Advocates Against State Farm's Rate Increase
- Rhode Island Teamsters Push for Ban on Forced Meetings at Work
- Costco Fleet Drivers Achieve Significant Contract Wins
- Data Breach Alert: Jacksonville Medical and Cabot Medical's Response
- BioVaxys Technology Corp. Announces Important Management Updates
- Celebrating Dr. Paul Delbert Winchester's Neonatology Journey
- Celebrating Dr. Uma Lele's Exceptional Leadership in Agriculture
- Titan Acquisition Corp Successfully Completes $276 Million IPO
- Oncolytics Biotech Partners with Alumni Capital for Growth
- Halozyme's FDA Approval of VYVGART: A Game-Changer for Patients
- Zahid F. Sarder Saddi's Call for Action Against Persecution
- Top-Ranked U.S. Apps and Websites for Programmatic Ads Revealed
- Navigating the Challenges of 55+ Housing Markets in 2025
- Key Trends in the 55+ Housing Market for Buyers and Sellers
- Immuron Achieves Unprecedented Growth with Travelan® Sales
- CXI Forms Strategic Alliance to Enhance Currency Exchange Services
- Matthew March Joins West Coast Community Bank as CIO
- Alabama Ophthalmology Associates Shares Update on Data Incident
- VYVGART Hytrulo Now Available for Self-Injection Treatment
- XENICAL's Role in Addressing Global Obesity Challenges
- U.S. Congressman Supports Bangladeshi Youth Movement for Democracy
- P. Peter Pascali's Strategic Shareholding Update at PyroGenesis
- Hut 8 Unveils Q1 2025 Financial Results and Conference Details
- Transforming Patient Care with Glow-in-the-Dark Labels
